Ophthalmology · Adrian, MI
NPI
1720164973
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1801 W Maumee St Ste 100
Adrian, MI, 49221
Phone (517) 265-6131
Groups this clinician bills Medicare through
Medicare paid, 2024
$272K
4,759 services
Medicare patients, 2024
746
Average age 76
Drug cost, 2024
$438K
1,752 prescriptions
Company payments, 2025
$1,324
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rashawn W Venerable was code 92014 (ophthalmological e&m), 302 times for 289 patients. In total Rashawn W Venerable billed 4,759 services in 60 codes, and Medicare paid $272K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-02-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 302 | 289 | $76.30 | $23K |
| 99213 Office E&M - Established | Office | 232 | 188 | $58.64 | $14K |
| 92012 Ophthalmological E&M | Office | 216 | 173 | $54.96 | $12K |
| 92133 Computerized Ophthalmic Imaging | Office | 128 | 121 | $22.09 | $2,827 |
| 92083 Vision, Hearing, and Speech Services | Office | 128 | 123 | $42.01 | $5,377 |
| 99203 Office E&M - New | Office | 125 | 125 | $61.79 | $7,724 |
| 92081 Vision, Hearing, and Speech Services | Office | 118 | 118 | $19.74 | $2,329 |
| 66984 Cataract Surgery | Facility | 114 | 67 | $353.91 | $40K |
| 92134 Computerized Ophthalmic Imaging | Office | 106 | 101 | $26.71 | $2,831 |
| 99214 Office E&M - Established | Office | 97 | 91 | $77.91 | $7,557 |
| 92136 Ultrasound - Nonspecific | Office | 88 | 86 | $32.69 | $2,876 |
| 92285 Standard X-ray | Office | 84 | 84 | $14.72 | $1,237 |
| 67904 Eye | Office | 76 | 52 | $612.25 | $47K |
| 99204 Office E&M - New | Office | 57 | 57 | $103.69 | $5,910 |
| 92020 Ophthalmological E&M | Office | 56 | 56 | $16.63 | $931 |
By year: 2022 $232K for 4,161 services; 2023 $298K for 5,141 services; 2024 $272K for 4,759 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rashawn W Venerable prescribed most often to Medicare patients was Neomycin-Polymyxin-Dexameth (Neomycin/Polymyxin B/Dexametha), with 469 prescriptions and refills. In total Rashawn W Venerable wrote 1,752 Medicare prescriptions that cost $438K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 469 | 503 | 332 | $5,524 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 233 | 240 | 186 | $1,784 |
| Latanoprost Generic | 148 | 374 | 44 | $2,759 |
| Ketorolac Tromethamine Generic | 89 | 124 | 52 | $1,856 |
| Azithromycin Generic | 72 | 72 | 54 | $248 |
| Lumigan Bimatoprost | 66 | 153 | 19 | $37K |
| Cyclosporine Generic | 51 | 117 | 18 | $30K |
| Timolol Maleate Generic | 49 | 121 | 17 | $779 |
| Brimonidine Tartrate Generic | 46 | 95 | 14 | $4,029 |
| Prednisolone Acetate Generic | 46 | 89 | 31 | $2,217 |
| Restasis Cyclosporine | 43 | 75 | 16 | $46K |
| Doxycycline Hyclate Generic | 43 | 78 | 15 | $902 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 38 | 59 | 27 | $2,553 |
| Erythromycin Erythromycin Base | 37 | 39 | 24 | $722 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 36 | 77 | 11 | $981 |
Brand drugs: 608 claims; generic drugs: 1,144 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rashawn W Venerable $1,324 ($1,324 in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbvie Inc. with $391.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 16 | $391 |
| Tarsus Pharmaceuticals, Inc. TARS | 9 | $325 |
| Amgen Inc. AMGN | 12 | $158 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 4 | $96.32 |
| Alcon Vision LLC ALC | 4 | $77.03 |
| Bausch & Lomb Americas Inc. BLCO | 4 | $67.97 |
| Glaukos Corporation GKOS | 1 | $52.78 |
| Astellas Pharma US Inc 4503.T | 1 | $29.54 |
| Oyster Point Pharma, Inc. | 1 | $25.16 |
| Merz Pharmaceuticals, LLC | 1 | $23.02 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.